283 related articles for article (PubMed ID: 21138335)
1. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer.
Patel MM; Amin AF
Drug Deliv; 2011 May; 18(4):281-93. PubMed ID: 21138335
[TBL] [Abstract][Full Text] [Related]
2. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets.
Gao C; Huang J; Jiao Y; Shan L; Liu Y; Li Y; Mei X
Int J Pharm; 2006 Sep; 322(1-2):104-12. PubMed ID: 16806752
[TBL] [Abstract][Full Text] [Related]
3. Formulation and development of di-dependent microparticulate system for colon-specific drug delivery.
Patel MM
Drug Deliv Transl Res; 2017 Apr; 7(2):312-324. PubMed ID: 28138901
[TBL] [Abstract][Full Text] [Related]
4. Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies.
Shah N; Sharma OP; Mehta T; Amin A
Drug Dev Ind Pharm; 2016; 42(5):825-35. PubMed ID: 27019195
[TBL] [Abstract][Full Text] [Related]
5. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet.
Srivastava R; Kumar D; Pathak K
Int J Pharm; 2012 May; 427(2):153-62. PubMed ID: 22306039
[TBL] [Abstract][Full Text] [Related]
6. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma.
Patel MM; Amin AF
J Pharm Sci; 2011 May; 100(5):1760-72. PubMed ID: 21154966
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
[TBL] [Abstract][Full Text] [Related]
8. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
[TBL] [Abstract][Full Text] [Related]
9. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
10. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine.
Vemula SK
Int J Pharm; 2015 Aug; 491(1-2):35-41. PubMed ID: 26056929
[TBL] [Abstract][Full Text] [Related]
11. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
Jadiya S; Upmanyu N; Sathiyanarayanan A; Jain V; Dubey R; Buwade P
J Pharm Sci; 2024 Jul; 113(7):1919-1926. PubMed ID: 38401631
[TBL] [Abstract][Full Text] [Related]
12. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
Kumar RV; Sinha VR
Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
[TBL] [Abstract][Full Text] [Related]
13. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
Rujivipat S; Bodmeier R
Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
Patel MM; Amin AF
Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
[TBL] [Abstract][Full Text] [Related]
15. Formulation, evaluation and pharmacokinetics of colon targeted pulsatile system of flurbiprofen.
Veerareddy PR; Vemula SK
J Drug Target; 2012 Sep; 20(8):703-14. PubMed ID: 22845842
[TBL] [Abstract][Full Text] [Related]
16. Solid dispersion of meloxicam: factorially designed dosage form for geriatric population.
Pathak D; Dahiya S; Pathak K
Acta Pharm; 2008 Mar; 58(1):99-110. PubMed ID: 18337211
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
Asghar LF; Chandran S
Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
[TBL] [Abstract][Full Text] [Related]
18. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.
Ghorab MM; Abdel-Salam HM; El-Sayad MA; Mekhel MM
AAPS PharmSciTech; 2004 Jul; 5(4):e59. PubMed ID: 15760056
[TBL] [Abstract][Full Text] [Related]
19. Evaluating bioequivalence of meloxicam tablets: is in-vitro dissolution test overdiscriminating?
Jin C; Zhao C; Shen D; Dong W; Liu H; He Z
J Pharm Pharmacol; 2018 Feb; 70(2):250-258. PubMed ID: 29193077
[TBL] [Abstract][Full Text] [Related]
20. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
